| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8623817 | Seminars in Arthritis and Rheumatism | 2018 | 30 Pages |
Abstract
Moderate-to-severe TID, but not TII, was a strong predictor of ESRD progression independent of eGFR or glomerular findings, therefore, providing an important window for potential early interventions.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Anna MD, MSc, Wenzhu B. PhD, Hina N. MD, Bojana MD, Alejandra MD, Peter MD, Chaim MD,